Journal of Applied Physiology AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Appl Physiol (February 14, 2008). doi:10.1152/japplphysiol.00865.2007
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
104/4/1101    most recent
00865.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Almlen, A.
Right arrow Articles by Curstedt, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Almlen, A.
Right arrow Articles by Curstedt, T.
Submitted on August 10, 2007
Accepted on February 13, 2008

Surfactant proteins B and C are both necessary for alveolar stability at end-expiration in premature rabbits with respiratory distress syndrome

Andreas Almlen1, Guido Stichtenoth1, Bim Linderholm1, Marie Haegerstrand-Bjorkman1, Bengt Robertson2, Jan Johansson3, and Tore Curstedt4*

1 Molecular Medicine and Surgery, Clinical Chemistry, Stockholm, Sweden
2 Molecular Medicine and Surgery, Clinical Chemistry, Stockholm, Sweden; United States
3 Anatomy, Physiology and Biochemistry, Uppsala, Sweden
4 Molecular Medicine and Surgery, Clinical Chemistry, Stockholm, Sweden; , Swaziland

* To whom correspondence should be addressed. E-mail: Tore.Curstedt{at}karolinska.se.

Modified natural surfactant preparations, used for treatment of respiratory distress syndrome (RDS) in premature infants, contain phospholipids and the hydrophobic proteins SP-B and SP-C. Herein the individual and combined effects of SP-B and SP-C were evaluated in premature rabbit foetuses treated with airway instillation of surfactant and ventilated without positive end-expiratory pressure. Artificial surfactant preparations composed of synthetic phospholipids 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)/1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine/1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG)/1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphoethanolamine, 55:25:15:5 (by weight) or DPPC/POPG, 68:31 (w/w), mixed with either 2% (w/w) of porcine SP-B, SP-C, or a synthetic poly-Leu analogue of SP-C (SP-C33) dido not stabilise the alveoli at the end of expiration, as measured by low lung gas volumes of about 5 ml/kg after 30 min of ventilation (modified natural surfactant 18 ml/kg, untreated controls 1-2 ml/kg). However, treatment with phospholipids containing both 2% SP-B and mixed with 2% SP-C/SP-C33 approximately doubled lung gas volumes.gave lung gas volumes of 11 ml/kg, while treatment with phospholipids containing 4% SP-C33 gave lung gas volumes of only 4-5 ml/kg. Doubling the SP-C33 content did not affect lung gas volumes. The tidal volumes were similar in all groups receiving surfactant. This shows that SP-B and SP-C exerts different physiological effects, sincethat both proteins are needed to establish alveolar stability at end-expiration in this animal model of RDS, and that an optimal synthetic surfactant probably requires the presence of mimics of both SP-B and SP-C.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1948 by the American Physiological Society.